Depression and Anxiety Trial, Not Yet Recruiting NCT07664540 Sponsor: University of Zurich Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Not Yet Recruiting

NCT07664540
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 18 and 40 years old
  • People with a BMI between 18.5 and 24.9 (for study groups 1 and 2) or a BMI between 25.0 and 39.9 (for study groups 3 and 4)
  • People who are able to understand what the study involves and agree to take part
  • People who have provided written consent to participate
  • Women in study group 1: any fitness level is accepted
  • Men in study group 2: a cardiorespiratory fitness level (VO2max) below 45 ml/kg/min, as measured by the trial site (confirm with trial site)
  • Women in study groups 1 and 3: people who are available to complete a fitness test (CPET) on days 1 to 5 of their menstrual cycle
  • People who do not have HIV or Hepatitis B or C

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had an infectious illness within the two weeks before the test
  • People who have taken vitamin supplements in the week before the performance test
  • People in study groups 3 and 4 who do more than one hour of moderate exercise per week
  • Women in study groups 1 and 3 who have used hormonal contraceptives in the six months before the study begins
  • Women in study groups 1 and 3 who have a diagnosed menstrual disorder, such as polycystic ovarian syndrome or absence of periods
  • Women in study groups 1 and 3 who have given birth within the 12 months before joining the study
  • Women in study groups 1 and 3 who are pregnant or breastfeeding
  • Women in study groups 1 and 3 who have premenstrual dysphoric disorder (PMDD)
  • People with a history of epileptic seizures
  • People with a history of depression
  • People with a history of a manic or psychotic episode
  • People who have had an eating disorder such as bulimia nervosa or anorexia nervosa within the past five years
  • People who are unable to communicate adequately through speech
  • People who are unable to follow instructions
  • People who regularly take any medication other than thyroxine
  • People whose average daily alcohol intake exceeds 12 grams of pure alcohol per day (for women) or 24 grams of pure alcohol per day (for men)
  • People who follow a vegan diet
  • People who use nicotine daily
  • People who currently use or have a history of regular illegal drug use within the past year
  • People with a known heart or cardiovascular condition
  • People with resting blood pressure above 160/90 mmHg
  • People with a known lung condition
  • People with arthritis or rheumatic diseases
  • People with blood-related (hematologic) diseases
  • People with bronchial asthma
  • People who have had surgery within the past four to six months
  • People with bone, joint, neurological, or other conditions that would prevent safe maximum effort on a stationary exercise bike
  • People with low red blood cell levels (anaemia), defined as below 12.0 g/dl for women and below 14.0 g/dl for men

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 September 2026
Est. completion
30 September 2029

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

Autophagic Flux in Peripheral Blood Mononuclear Cells (PBMCs)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov